IMMUDEX ApS is a Danish APS based in Virum, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2008, the company has 37 employees and reported a gross profit of DKK 22.7m in its latest annual filing.
EBITDA margin (of gross profit) −39.7 %
−14% vs 2024
Solidity ratio Equity ÷ Total assets × 100 Among the 40% lowest rated companies in the industry
2021 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 30% lowest rated companies in the industry
2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 20% lowest rated companies in the industry
2021 2025
EBITDA — year on year DKK thousands 5287 828 -3630 -8088 -12547 2021: 1774 1774 2021 2022: -9034 (-609% vs 2021) -9034 -609% 2022 2023: 36 (+100% vs 2022) 36 +100% 2023 2024: -7918 (-22094% vs 2023) -7918 -22094% 2024 2025: -9006 (-14% vs 2024) -9006 -14% 2025
Key figures Annual report 2025 Gross profit 22.7M DKK -10% EBITDA -9M DKK -14% Net profit -11M DKK -55% Total assets 49.1M DKK +5% Equity 16.1M DKK -36% Employees 37 —
Founded
1 April 2008 · 18 years
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsens formand eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er kommercialisering af immunmonitorerings metoder
(no translation available)
Website
https://www.immudex.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), IMMUDEX ApS reported a gross profit of DKK 22.7m, a decrease of 10% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 11.0m, and the EBITDA margin stood at -39.7%.
At the end of 2025, equity financed 32.7% of the balance sheet, and current assets covered short-term debt 1.2 times. IMMUDEX ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of IMMUDEX ApS? IMMUDEX ApS is registered with CVR / Virk under CVR 31348854.
What is the gross profit of IMMUDEX ApS? IMMUDEX ApS reported a gross profit of DKK 22.7m in 2025.
How many employees does IMMUDEX ApS have? IMMUDEX ApS employs 37 people as of the latest annual report.
Who is the CEO of IMMUDEX ApS? Patrik Olof Dahlén is the CEO of IMMUDEX ApS, in role since 2022.
Who is the chairman of IMMUDEX ApS? Søren Elmann Ingerslev chairs the board of IMMUDEX ApS, in role since 2014.
Where is IMMUDEX ApS headquartered? IMMUDEX ApS's registered address is Bredevej 2A.
